About Ambry Genetics
Ambry Genetics is a Healthcare company based in Aliso Viejo (United States) founded in 1999 by Charles L M Dunlop, and was acquired by Tempus in November 2024. Genetic testing is provided for clinical diagnostics and genomic services. Ambry Genetics has completed 2 acquisitions, including GenomeSmart and Progeny Genetics. Its website ambrygen.com draws about 189 thousand monthly visits. Its focus areas include Clinical Laboratories and Diversified.
Company details
Ambry Genetics was founded in 1999 in Aliso Viejo, United States, within the healthcare sector specializing in genomics. Clinical diagnostics and genomic services are delivered, including gene sequence analysis, customizable sequencing, genotyping, and microarray options. Clinical resources are supplied to facilitate clinician education and data sharing, which supports scientific discoveries aimed at enhancing patient management and care. Operations are centered on advancing genetic testing applications.
- Headquarters Aliso Viejo, United States
- Founders Charles L M Dunlop
- Stage Acquired
- SectorsHealthcare
- Website category Health · Health Conditions and Concerns
- Phoneβ’β’β’β’ β’β’β’β’
- Website ambrygen.com
- Social LinkedIn X Facebook YouTube
- Acquired by Konica Minolta (Jul 2017)
- Legal Name Ambry Genetics
- Latest Funding Round$400K (USD), Grant
Jun 2023
- InvestorsKonica Minolta
& 3 more
- Investments & AcquisitionsGenomeSmart
& 1 more
- Acquired by
Apps and channels of Ambry Genetics
its YouTube channel Ambry Genetics has 5.09K subscribers and 30 videos.
Videos from Ambry Genetics
The most watched videos on Ambry Genetics's YouTube channel, Ambry Genetics (5.09K subscribers). Click a video to play it here.
More on Ambry Genetics.
Funding Insights of Ambry Genetics
- Total Rounds 9
- Last Round Grant β $400,000
- First Round $725,000
(Jun 2015)
- Investors Count 1
All 9 funding rounds of Ambry Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $400,000 | Grant | β | β | |
| Jun 2022 | $800,000 | Grant | β | β | |
| Jun 2021 | $800,000 | Grant | β | β | |
| Jun 2020 | $900,000 | Grant | β | β | |
| Jun 2019 | $800,000 | Grant | β | β | |
| Jun 2018 | $800,000 | Grant | β | β | |
| Jun 2017 | $1.13M | Grant | β | β | |
| Jun 2016 | $824,999 | Grant | β | β | |
| Jun 2015 | $725,000 | Grant | β | β |
4 investors in total: 4 institutional.
Investors in Ambry Genetics
Ambry Genetics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Konica Minolta, Tempus and Health Resources and Services Administration.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment activities in various industries are conducted by INCJ. | incj.co.jp | |||
Health services and resources are provided by HRSA nationwide. | hrsa.gov | Rockville, United States | ||
Konica Minolta is engaged in providing imaging and printing solutions. | 1873 | konicaminolta.com | Tokyo, Japan | |
AI-based precision medicine solutions for oncology are provided. | 2015 | tempus.com | Chicago, United States |
Investor details for Ambry Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ambry Genetics
153 people are tracked at Ambry Genetics (53 in leadership, 100 in team).
| Name | Role | Group |
|---|---|---|
Charles L M Dunlop | Founder | Leadership |
Donavan Cheng | Chief Science And Technology Officer | Leadership |
Tom Schoenherr | CEO | Leadership |
Beth Erdman | Sr. Director Digital Health Operations | Leadership |
Pari Hemyari | Senior Director Of Statistical Genetics | Leadership |
Samantha Mitchell Tillman | Associate Director Of Finance | Leadership |
Kelly Radtke | Director, Clinical Diagnostics | Leadership |
Elizabeth Chao | VP, Clinical Diagnostics Laboratory Director | Leadership |
Saba Sherzai | Talent Acquisition Partner | Leadership |
Frank Vandenhouten | Sr. Region Vice President | Leadership |
Michael Martinson | Chief Financial Officer | Leadership |
Menzies Chen | Sr. Director, Product Management | Leadership |
H.paul Wan | Associate Laboratory Technical Director | Leadership |
Carole Oddoux | Associate Technical Director | Leadership |
Candace Peterson | Regional Medical Affairs Director | Leadership |
Tina Pesaran Ma | Vp, Genomic Science | Leadership |
Mickie Henshall | Chief Business Officer | Leadership |
Christina Alamillo | Medical Affairs Director | Leadership |
Emily Kudalkar | Associate Laboratory Director | Leadership |
Cody Buhler | Sr. Director Of Business Development | Leadership |
133 more people are available in the full profile.
Complete people profiles for Ambry Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ambry Genetics
Ambry Genetics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include GenomeSmart and Progeny Genetics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Genetic analysis platform is developed for medical history assessments. | genomesmart.com | California, United States | 2015 | Feb 2020 | β’β’β’β’ | |
Risk modeling and genetic pedigree software solutions are offered. | progenygenetics.com | Delray Beach, United States | 1996 | Apr 2015 | β’β’β’β’ |
Complete acquisition details for Ambry Genetics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ambry Genetics
7 dated milestones of Ambry Genetics across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Ambry Genetics is founded.
- Acquisition Acquires Progeny Genetics.
- Funding First funding round of $725K.
- Exit Acquired by Konica Minolta.
- Acquisition Acquires GenomeSmart.
- Funding Latest funding round, Grant, of $400K.
- Exit Acquired by Tempus.
Web traffic of Ambry Genetics
The website of Ambry Genetics (ambrygen.com) receives about 189.2K visits a month and ranks #206,714 among all websites worldwide, #6,728 in Health Conditions and Concerns.
- Monthly visits189.2K
▲ 3% vs previous month
- Unique visitors78.1K
per month
- Global rank#206,714
among all websites
- Category rank#6,728
Health · Health Conditions and Concerns
- Bounce rate30%
- Pages per visit3.2
- Average visit4 min 06 sec
- DevicesDesktop 37% Β· Mobile 63%
Websites whose visitors overlap most with Ambry Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| invitae.com | 100% | 439.4K | #95,124 | View details | |
| nccn.org | 88% | #61,038 | View details | ||
| preventiongenetics.com | 84% | 24.4K | #1,074,192 | View details | |
chginc.org | chginc.org | 79% | #4,308,561 | β | |
pancreasfoundation.org | pancreasfoundation.org | 78% | #1,271,719 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 38 similar websites and full traffic analytics for Ambry Genetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 38 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics Laboratories
2 companies that operate in the same segment as Ambry Genetics (Diagnostics Laboratories) in United States, ranked by their profile score on The Company Check.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ambry Genetics
Complete news archive for Ambry Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ambry Genetics
Ambry Genetics was founded in 1999 and raised its 1st funding round 16 years after it was founded.
Ambry Genetics is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Ambry Genetics was founded in 1999 in Aliso Viejo, United States, within the healthcare sector specializing in genomics. Clinical diagnostics and genomic services are delivered, including gene sequence analysis, customizable sequencing, genotyping, and microarray options. Clinical resources are supplied to facilitate clinician education and data sharing, which supports scientific discoveries aimed at enhancing patient management and care. Operations are centered on advancing genetic testing applications.
Ambry Genetics has made 2 acquisitions, including GenomeSmart, and Progeny Genetics.
Ambry Genetics has 4 investors. Key investors include Konica Minolta, Tempus, Health Resources and Services Administration, and INCJ.
Ambry Genetics operates through Ambry Genetics.
Yes. Ambry Genetics was acquired by Konica Minolta in July 2017.
The website of Ambry Genetics receives about 189 thousand visits a month and ranks #206,714 among all websites worldwide.

